2 Under-the-Radar COVID Vaccine Stocks to Buy for 2021
Moderna and Pfizer were first to market with their coronavirus vaccines. The U.S. Food and Drug Administration (FDA) granted them both Emergency Use Authorization (EUA) last month. But that doesn't mean the vaccine race is over. Considering global demand, there is plenty of room for other players.
Still, once the crisis has eased and vaccination becomes routine rather than urgent, certain players may emerge as market leaders. The type of vaccine that can stand out in the crowd would be one offering ease of use and few distribution challenges. Today, Vaxart (NASDAQ: VXRT) and Altimmune (NASDAQ: ALT) are working on exactly those kinds of products. Let's take a closer look at these under-the-radar coronavirus vaccine stocks.
Image source: Getty Images.
Source Fool.com
